/Companies

Elypta

9 known investors

Find your way into Elypta

Sign up to see every warm intro you have to Elypta

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Elypta team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Elypta develops a metabolism-based liquid biopsy that measures the GAGome, a set of biomarkers of tumor metabolism, and applies machine learning to noninvasively detect cancer signatures. The company focuses on early cancer detection to reduce cancer mortality.

Founders & leadership

FGFrancesco Gatto
Francesco GattoFounder and Scientific Advisor
JNJens Nielsen
Jens NielsenChairman, Founder

Investors · 9

Funding

SEC filings, press & company announcements

$21M disclosed across 1 of 2 rounds · 2020–2022

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Frequently asked questions

What does Elypta do?
Elypta develops a metabolism-based liquid biopsy that measures the GAGome, a set of biomarkers of tumor metabolism, and applies machine learning to noninvasively detect cancer signatures. The company focuses on early cancer detection to reduce cancer mortality.
Who founded Elypta?
Elypta was founded by Francesco Gatto, Jens Nielsen.
Who are Elypta's investors?
Elypta's investors include Bonnier Capital, Chalmers Ventures AB, Industrifonden, Navigare Ventures, Nina Capital, Bonnier Ventures, Norrsken Accelerator, Norrsken VC and 1 more.
How much funding has Elypta raised?
Elypta has disclosed $21M raised across 1 of its 2 known rounds.